Search Results
Apr 20, 2026, 09:00 ET Khachkar Studios Unveils BREAKTHROUGHS for Judeo-Christian Leaders
growth.Masterclass #1: Growing the "Faithful" introduces a biblically inspired "Framework" for transparency, accountability, and performance (T•A•P).Khachkar Studios noted:"Scores of respected media outlets have already described Masterclass #1 as a historic initiative
More news about: The Charles & Agnes Kazarian Foundation
Apr 20, 2026, 09:00 ET Silver Above US$80 and a Sixth Straight Year of Deficits -- This Ontario Consolidator Is Targeting Ground Where 50+ Million Ounces Were Produced on Either Side of a Claim Line
acquired leases, a historical NI 43-101 indicated tailings resource totals approximately 1,940,000 tonnes grading 47.5 g/t Ag for approximately 2,960,000 contained ounces of silver at a 10 g/t cut-off (GeoVector Management, 2011).[1][5] Historical testwork at Lakefield Research achieved silver recoveries
More news about: Equity Insider
Apr 20, 2026, 09:00 ET KyCOMPASS Selects Trayt Health to Digitally Power Kentucky's Maternal Mental Health Access Program
capacity"KyCOMPASS was created to bring maternal psychiatric expertise directly into the settings where patients already receive care," said Dr. Audrey T. Summers, KyCOMPASS Medical Director. "Deploying Trayt Health's platform enhances our ability to respond quickly to providers, coordinate care effectively,
More news about: Trayt Health
Apr 20, 2026, 09:00 ET Eclipsebio Launches eCOMPASS™, an AI-Enabled Lab-in-the-Loop Platform for RNA Therapeutic Development
lab-in-the-loop platform, an integrated Design, Make, Test solution for RNA therapeutic development. The platform supports programs across vaccines, CAR-T therapies, gene editing, and protein replacement.
More news about: Eclipsebio
Apr 20, 2026, 09:00 ET Primark To Open Flagship Store in Manhattan's Herald Square on May 8
and the Middle East, employing more than 80,000 colleagues. Millions of shoppers trust Primark every week for everything from everyday essentials like t-shirts and socks, to the latest fashion trends – all at unbeatable prices.Primark is built on a belief and passion for physical stores – helping
More news about: Primark
Apr 20, 2026, 08:18 ET 2026 AACR：易慕峰生物IMV102體內CAR-T實現持久腫瘤控制，臨床前數據發佈
IFN-γ水平均處於可控範圍內，體現出免疫活性與安全性的良好平衡。易慕峰生物董事長&CEO孫敏敏博士表示：「IMV102的積極進展進一步驗證了公司『體外CAR-T + 體內CAR-T』雙引擎戰略的前瞻性與可行性。體內CAR-T
More news about: 易慕峰生物
Apr 20, 2026, 08:18 ET Sigenergy, Başarılı SolarEx İstanbul 2026 Katılımının Ardından Türkiye'deki Pazar Konumunu Güçlendiriyor
bölgedeki marka görünürlüğünü önemli ölçüde artırdı. Yerel distribütörü Redsun Enerji ile iş birliği yapan Sigenergy; konut, ticari ve endüstriyel (T&E) ve şebeke ölçekli çözümlerden oluşan tüm portföyünü sektör profesyonellerinden oluşan son derece ilgili bir kitleye sergiledi.
More news about: Sigenergy
Apr 20, 2026, 08:00 ET AT&T and Citi Enhance the AT&T Points Plus Card
ways for AT&T customers to save money and maximize rewardsKey Takeaways:Citi and AT&T introduce new benefits for the AT&T Points Plus® Card, delivering more value and savings.Card benefits now include monthly AT&T wireless
More news about: AT&T
Apr 20, 2026, 08:00 ET Deck Bio Presents Preclinical Data on DBXO-1, a Multi-pMHC Targeted T Cell Engager, at AACR 2026
immunotherapies to unlock the potential of T cell engagers in solid tumors. The company is advancing a differentiated platform of multi-pMHC targeted T cell engagers designed to improve safety, patient access, and durability of response. Its approach integrates a proprietary T cell receptor stabilization technology
More news about: Deck Bio, Inc.
Apr 20, 2026, 08:00 ET Adcendo ApS Provides Updates on Pipeline Progress and Recent Achievements for Its First- and Best-in-Class Antibody-Drug Conjugates
ADCE-T02, a potential best-in-class Tissue Factor targeted antibody-drug conjugate (ADC), enters cohort expansion portion of the Tiffany-01 study in advanced solid tumorsTwo ADCE-T02 publications highlighting important preclinical results at the
More news about: Adcendo
Apr 20, 2026, 08:00 ET Adcendo ApS Provides Updates on Pipeline Progress and Recent Achievements for Its First- and Best-in-Class Antibody-Drug Conjugates
ADCE-T02, a potential best-in-class Tissue Factor targeted antibody-drug conjugate (ADC), enters cohort expansion portion of the Tiffany-01 study in advanced solid tumorsTwo ADCE-T02 publications highlighting important preclinical results at the
More news about: Adcendo
Apr 20, 2026, 07:50 ET Medtronic completes acquisition of CathWorks, expanding its leadership in transforming care for patients with cardiovascular disease
Guide PCI. The New England Journal of Medicine 2026; DOI: 10.1056/NEJMoa26009492. H. Omori, G. Witberg, Y. Kawase, T. Tanigaki, S. Okamoto, T. Hirata, Y. Sobue, H. Ota, H. Kamiya, M. Okubo, O. Valzer, R. Kornowski, H. Matsuo. Angiogram based fractional flow reserve in patients with
More news about: Medtronic plc
Apr 20, 2026, 07:30 ET 52-Week Topline Results from 16-Week Blinded Treatment Extension of REZOLVE-AA Demonstrate Deepening of Responses in Severe-to-Very-Severe Alopecia Areata with Rezpegaldesleukin
period in its Phase 2b REZOLVE-AA study. The study is evaluating investigational rezpegaldesleukin, a first-in-class IL-2 pathway agonist and regulatory T-cell (Treg) biologic, in patients with severe-to-very-severe alopecia areata.
More news about: Nektar Therapeutics
Apr 20, 2026, 06:30 ET PermRock Royalty Trust Declares Monthly Cash Distribution
underlying the Trust totaled $0.82 million for the current month, an increase of $0.13 million from the prior month's distribution period. T2S Permian Acquisition II LLC ("T2S") informed the Trust that this increase was primarily due to an increase in oil sales volumes and oil prices.Natural gas cash
More news about: PermRock Royalty Trust
Apr 20, 2026, 06:30 ET AGNICO EAGLE TO CONSOLIDATE FINLAND'S CENTRAL LAPLAND GREENSTONE BELT IN THREE SEPARATE TRANSACTIONS
resource base – probable mineral reserves of 3.5 million ounces of gold (52.0 million tonnes at 2.10 g/t) from indicated mineral resources of 4.1 million ounces of gold (58.4 million tonnes at 2.18 g/t) (inclusive of mineral reserves)Land consolidation with the Fingold JV creates additional value,
More news about: Agnico Eagle Mines Limited
Apr 20, 2026, 06:07 ET Immunofoco Presents Preclinical Data for IMV102, an In Vivo CAR-T Candidate, Demonstrating Durable Tumor Control at the AACR 2026
vector-based in vivo CAR-T system composed of a mutated MxV glycoprotein (MxV-G-mut) and a T cell targeting module (TCM3). This platform enables selective targeting and transduction of T cells in vivo.Leveraging this platform, the company is advancing IMV102, a BCMA-targeting in vivo CAR-T candidate that
More news about: Immunofoco
Apr 20, 2026, 04:17 ET Fapon Biopharma Presents at AACR Annual Meeting 2026, Showcasing Core Technology Platforms and Advancing Pipeline
company's expanding CD3/TCR VHHs, including FPE024, a potential best-in-class CD19xBCMAxCD3 tri-specific T-cell engager for autoimmune indications, and FPE021, a potential best-in-class CDH17-targeting T-cell engager with a second signal for gastrointestinal tract cancers. Both programs are expected to enter
More news about: Fapon Biopharma
Apr 20, 2026, 02:57 ET AlphaGen Therapeutics to Present Preclinical Studies of Two Next-Generation Alpha Therapies at AACR 2026
non-agonist SSTR2-targeting alpha radiopharmaceutical. In preclinical studies, the compound demonstrated high binding affinity and a superior tumor-to-kidney (T/K) ratio compared to agonist radioligands. It showed robust tumor growth inhibition and survival benefit across multiple models with a very favorable safety
More news about: AlphaGen Therapeutics
Apr 20, 2026, 02:30 ET New Combination Therapy for Advanced Small Cell, Lung Cancer Approved in Australia and Singapore
[Accessed Apr 2026].[3] John T, et al. Lung Cancer in Australia. J Thorac Oncol. 2020 Dec;15(12);1809-1814.
More news about: Specialised Therapeutics
Apr 19, 2026, 20:15 ET CStone Presented Preclinical Data for Three Novel or Differentiated ADCs at AACR 2026, Including CS5007 (EGFR/HER3)
Notes. *: Yoshida T. WCLC, 2025; 1: Chiang CL et al. Lung Cancer. 2024 Feb; 2: Heeke S et al. Cancer Cell. 2024 Feb CS5008 is a
More news about: CStone Pharmaceuticals
Apr 19, 2026, 15:00 ET SIRUI Wins "Best of Show", Unveils New Cine Lenses at NAB Show 2026
LAS VEGAS, April 19, 2026 /PRNewswire/ -- SIRUI today received a "Best of Show" award for its Vision Prime T1.4 Full-Frame Cine Lens Series, while also introducing new focal lengths for both the Vision Prime and IronStar lens families at the 2026 NAB Show. The
More news about: SIRUI
Apr 19, 2026, 12:00 ET Nektar to Hold Conference Call to Discuss 52-Week Topline Results from the 16-Week Extension Treatment Period for its REZOLVE-AA Phase 2b Study of Rezpegaldesleukin in Alopecia Areata on April 20, 2026
results from the 16-week extension treatment period of the ongoing Phase 2b REZOLVE-AA clinical trial of investigational rezpegaldesleukin, a regulatory T-cell (Treg) proliferator, for severe-to-very-severe alopecia areata on Monday, April 20, 2026 at 8:00 am ET / 5:00 am PT.
More news about: Nektar Therapeutics
Apr 19, 2026, 10:20 ET Quickplay's Triple Play of New Customers, Products and Partnerships Set to Dominate NAB 2026
served and 99.999% streaming uptime. Quickplay was founded by four innovators with deep media and entertainment technology experience from AT&T, McKinsey and Company, The Walt Disney Company, and Warner Bros. Discovery. Headquartered in Toronto, the company has offices in Los Angeles, San Diego,
More news about: Quickplay
Apr 19, 2026, 10:01 ET Television New Zealand Partners with Quickplay to Fully Transform Their OTT Platform, Evolving the Broadcaster into a World-Class Digital Platform
ad impressions served and 99.999% streaming uptime. Quickplay was founded by four innovators with deep media and entertainment technology experience from AT&T, McKinsey and Company, The Walt Disney Company, and Warner Bros. Discovery. Headquartered in Toronto, the company has offices in Los Angeles, San Diego,
More news about: Quickplay